- Investing Ideas
- Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Danish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
3
0 new
Companies which are potentially undervalued and in an acceptable financial position.
3 companies
Bavarian Nordic
Market Cap: DKK 15.4b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 200.20
7D
1.4%
1Y
32.0%
Novo Nordisk
Market Cap: DKK 1.2t
Engages in the research and development, manufacture, and distribution of pharmaceutical products.
NOVO B
DKK 260.40
7D
8.2%
1Y
-38.2%
H. Lundbeck
Market Cap: DKK 40.6b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 42.44
7D
5.1%
1Y
48.6%